Detalles de la búsqueda
1.
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.
Diabetes Obes Metab
; 25(1): 46-55, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36111434
2.
Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain.
BMC Health Serv Res
; 23(1): 1340, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38041087
3.
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
Am Heart J
; 243: 232-239, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34666013
4.
An Epidemiology Model for Estimating the Numbers of US Patients With Multiple Myeloma by Line of Therapy and Treatment Exposure.
Value Health
; 25(12): 1977-1985, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35963840
5.
Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain.
BMC Health Serv Res
; 22(1): 1241, 2022 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36209120
6.
Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study.
Diabetes Obes Metab
; 23(1): 39-48, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32845558
7.
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme.
Diabetes Obes Metab
; 22(1): 66-78, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31468637
8.
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme.
Diabetes Obes Metab
; 21(11): 2474-2485, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31297947
9.
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
Cardiovasc Diabetol
; 17(1): 150, 2018 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30486889
10.
Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.
Diabetes Obes Metab
; 20(2): 389-399, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28817227
11.
Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model.
Pharmacoepidemiol Drug Saf
; 25(8): 871-9, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27476979
12.
Prevalence of gastrointestinal stromal tumour (GIST) in the United Kingdom at different therapeutic lines: an epidemiologic model.
BMC Cancer
; 14: 364, 2014 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24884940
13.
Considerations when planning and conducting large global observational studies: Experience from the DISCOVER study of patients with type 2 diabetes.
Prim Care Diabetes
; 17(5): 411-419, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37544790
14.
Burden of Illness beyond Mortality and Heart Failure Hospitalizations in Patients Newly Diagnosed with Heart Failure in Spain According to Ejection Fraction.
J Clin Med
; 12(6)2023 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36983410
15.
Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study.
Front Endocrinol (Lausanne)
; 13: 831676, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35527995
16.
Linaclotide utilization and potential for off-label use and misuse in three European countries.
Therap Adv Gastroenterol
; 15: 17562848221100946, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35706826
17.
Prevalence, Characteristics, Management and Outcomes of Patients with Heart Failure with Preserved, Mildly Reduced, and Reduced Ejection Fraction in Spain.
J Clin Med
; 11(17)2022 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36079133
18.
Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study.
Diabetes Res Clin Pract
; 180: 108974, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34302913
19.
Type 2 diabetes and heart failure: insights from the global DISCOVER study.
ESC Heart Fail
; 8(2): 1711-1716, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33570253
20.
Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme.
BMJ Open
; 10(8): e034613, 2020 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32868349